Download PDF
Klin Padiatr 2012; 224(06): 382-385
DOI: 10.1055/s-0032-1321875
Case Report
© Georg Thieme Verlag KG Stuttgart · New York

Surgery of a Cyanotic Heart Defect in an 11-year-old Boy with Thrombocytopenic Thrombocytopathy and Severe Anemia due to a GATA-1 Defect: Hemostatic Therapy

Korrektur eines zyanotischen Herzfehlers bei einem 11-jährigen Jungen mit thrombozytopenischer Thrombozytopathie und schwerer Anämie bei GATA-1 Transkriptionsdefekt: hämostatische Behandlung
J. Hoefer
1   Innsbruck Medical University, Anesthesiology and Intensive Care Medicine, Innsbruck, Austria
,
W. Streif
2   Innsbruck Medical University, Paediatrics, Innsbruck, Austria
,
J. Kilo
3   Innsbruck Medical University, Cardiac Surgery, Innsbruck, Austria
,
M. Grimm
3   Innsbruck Medical University, Cardiac Surgery, Innsbruck, Austria
,
G. Berger
2   Innsbruck Medical University, Paediatrics, Innsbruck, Austria
,
C. Velik-Salchner
1   Innsbruck Medical University, Anesthesiology and Intensive Care Medicine, Innsbruck, Austria
› Author Affiliations
Further Information

Publication History

Publication Date:
22 August 2012 (online)

Also available at
    Permissions and Reprints

Abstract

A child was admitted to our hospital for repair of a ventricular septal defect (VSD) characterized by a predominantly right-to-left shunt and a severe stenosis of the right ventricular outflow tract (Tetralogy of Fallot). Severe congenital anemia (hemoglobin 72 g/L), thrombocytopenia (42×G/L) and profound platelet dysfunction led a stem cell defect to be suspected. X-linked thrombocytopenia (GATA-1 mutation) was diagnosed. GATA-1 defect may complicate medical interventions due to excessive bleeding and partial or complete bone marrow failure. Maintaining a platelet count of 100 G/L and a maximal clot firmness (EXTEM-MCF) >50 mm allowed repair of the congenital heart defect without bleeding or hematological complications. Anemia and thrombocytopenia persisted after cardiac surgery, while the spontaneous bleeding tendency improved.

Zusammenfassung

Ein Kind wurde zur Korrektur eines angeborenen Ventrikel-Septum-Defekts (VSD) mit erheblichem Rechts-links Shunt und hochgradiger Stenose des rechtsventrikulären Ausflusstrakts (Fallot’schen Tetralogie) an unserer Klinik vorstellig. Eine bekannte schwere kongenitale Anämie (Hb 72 g/L), Thrombozytopenie (42×G/L), sowie ausgeprägte Thrombozytenfunktionsstörung führten zur Verdachtsdiagnose eines Stammzelldefektes. In der Folge konnte eine GATA-1 Mutation diagnostiziert werden. Im Rahmen dieses Defektes können Interventionen zu lebensbedrohlichen Blutungen führen oder ein partielles oder völliges Versagen des Knochenmarkes auslösen. Anheben der Thrombozytenzahl auf 100 G/L und Aufrechterhalten einer maximalen Gerinnselfestigkeit von 50 mm (EXTEM-MCF) ermöglichte die Korrektur des zyanotischen Herzfehlers ohne Komplikationen. Anämie und Thrombozytopenie persistierten nach dem herzchirugischen Eingriff, wobei sich die spontane Blutungsneigung deutlich besserte.

Key words

congenital heart surgery - GATA-1 defect - dyserythropoietic anemia - thrombocytopenia - thrombocytopathy

Supplementary Material

    The table 2 and figures 4 and 5 of this article can be found in internet as supplementary material with DOI http://dx.doi.org/10.1055/s-0032-1321875.
  • Supplementary Material:
 

  • References

  • 1 Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208
    CrossrefPubMedGoogle Scholar
  • 2 Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol 2010; 149: 813-823
    CrossrefPubMedGoogle Scholar
  • 3 Andreasen JB, Hvas AM, Christiansen K et al. Can RoTEM(R) analysis be applied for haemostatic monitoring in paediatric congenital heart surgery?. Cardiol Young 2011; 21: 684-691
    CrossrefPubMedGoogle Scholar
  • 4 Balduini CL, Cattaneo M, Fabris F et al. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 2003; 88: 582-592
    PubMedGoogle Scholar
  • 5 Cattaneo M, Hayward CP, Moffat KA et al. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009; 7: 1029
    CrossrefPubMedGoogle Scholar
  • 6 Freson K, Devriendt K, Matthijs G et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 2001; 98: 85-92
    CrossrefPubMedGoogle Scholar
  • 7 Haas T, Fries D, Velik-Salchner C et al. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008; 106: 725-731 table of contents
    CrossrefPubMedGoogle Scholar
  • 8 Halimeh S, Angelis G, Sander A et al. Multiplate whole blood impedance point of care aggregometry: preliminary reference values in healthy infants, children and adolescents. Klin Padiatr 2010; 222: 158-163
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Heimpel H, Anselstetter V, Chrobak L et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 2003; 102: 4576-4581
    CrossrefPubMedGoogle Scholar
  • 10 Hennewig U, Laws HJ, Eisert S et al. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a. Klin Padiatr 2005; 217: 365-370
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Henriksson P, Varendh G, Lundstrom NR. Haemostatic defects in cyanotic congenital heart disease. Br Heart J 1979; 41: 23-27
    CrossrefPubMedGoogle Scholar
  • 12 Jambor C, Bremerich D, Moritz A et al. Management of hemostasis disorders after extracorporeal circulation. A clinical therapy algorithm. Anaesthesist 2008; 57: 374-381
    CrossrefPubMedGoogle Scholar
  • 13 Klingebiel T, Creutzig U, Christaras A et al. Milestones of health policy and rare diseases. Klin Padiatr 2010; 222: 121-123
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lang T, Johanning K, Metzler H et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009; 108: 751-758
    CrossrefPubMedGoogle Scholar
  • 15 Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 2006; 98: 254-258
    CrossrefPubMedGoogle Scholar
  • 16 Lundin A, Richardsson A, Thore A. Continous monitoring of ATP-converting reactions by purified firefly luciferase. Anal Biochem 1976; 75: 611-620
    CrossrefPubMedGoogle Scholar
  • 17 Mehaffey MG, Newton AL, Gandhi MJ et al. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 2001; 98: 2681-2688
    CrossrefPubMedGoogle Scholar
  • 18 Mittermayr M, Streif W, Haas T et al. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 2008; 100: 307-314
    CrossrefPubMedGoogle Scholar
  • 19 O’Connell BA, Lee EJ, Rothko K et al. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood 1992; 79: 527-531
    PubMedGoogle Scholar
  • 20 Olbrich P, Parrilla Parrilla J, Caballero Eraso C et al. Combined Use of Recombinant Activated Factor VII and ECMO in Severe Postoperative Bleeding after Cardiac Surgery in a Newborn: Death due to Ventricular Dysfunction. Klin Padiatr 2012; 224: 193-194
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Rahe-Meyer N, Winterhalter M, Boden A et al. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaesthesiol Scand 2009; 53: 168-175
    CrossrefPubMedGoogle Scholar
  • 22 Sacher RA, Kickler TS, Schiffer CA et al. Management of patients refractory to platelet transfusion. Arch Pathol Lab Med 2003; 127: 409-414
    PubMedGoogle Scholar
  • 23 Streif W, Knofler R, Eberl W. Inherited disorders of platelet function in pediatric clinical practice: a diagnostic challenge. Klin Padiatr 2010; 222: 203-208
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Streif W, Oliveri M, Weickardt S et al. Testing for inherited platelet defects in clinical laboratories in Germany, Austria and Switzerland. Results of a survey carried out by the Permanent Paediatric Group of the German Thrombosis and Haemostasis Research Society (GTH). Platelets 2010; 21: 470-478
    CrossrefPubMedGoogle Scholar
  • 25 Tauer JT, Gneuss A, Lohse JE et al. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy. Klin Padiatr 2011; 223: 169-172
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Terai M, Nakazawa M, Takao A et al. Thrombocytopenia in patients with aortopulmonary transposition and an intact ventricular septum. Br Heart J 1987; 57: 371-374
    CrossrefPubMedGoogle Scholar
  • 27 Thies WR, Gobel U, Liersch R. Fibrinogen half-life in children with cyanotic congenital heart disease. Eur J Pediatr 1982; 139: 43-47
    CrossrefPubMedGoogle Scholar
  • 28 Velik-Salchner C, Haas T, Innerhofer P et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007; 5: 1019-1025
    CrossrefPubMedGoogle Scholar
  • 29 Vyas P, Ault K, Jackson CW et al. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999; 93: 2867-2875
    PubMedGoogle Scholar
  • 30 Wedemeyer AL, Edson JR, Krivit W. Coagulation in cyanotic congenital heart disease. Am J Dis Child 1972; 124: 656-660
    PubMedGoogle Scholar